Welcome to our dedicated page for Joint news (Ticker: JYNT), a resource for investors and traders seeking the latest updates and insights on Joint stock.
The Joint Corp. (NASDAQ: JYNT) is a national operator, manager and franchisor of chiropractic clinics under The Joint Chiropractic brand, and its news flow reflects both its role in healthcare and its franchise-driven growth strategy. Company press releases highlight its position as the nation’s largest provider of chiropractic care through a branded network that delivers millions of patient visits each year and operates more than 950 locations nationwide.
News about The Joint Corp. frequently covers financial results and operating metrics, including quarterly revenue trends, system-wide sales, comparable clinic sales and Adjusted EBITDA. These updates often discuss refranchising activity, the mix of franchised versus company-owned or managed clinics, and transactions involving the sale of groups of clinics to existing franchisees or franchise groups in regions such as Arizona, New Mexico, the Southeast and other markets.
Investors and observers can also expect announcements about strategic initiatives, such as the company’s multi-year plan to strengthen its core, reignite growth and improve profitability. Press releases have described efforts to become a pure play franchisor, acquire or adjust regional developer rights, and invest in marketing infrastructure, including search engine optimization, AI-search and a mobile app aimed at enhancing the patient experience.
In addition, The Joint Corp. issues news on brand recognition and expansion, including rankings in franchise industry lists, entry into new states and promotional campaigns under The Joint Chiropractic banner. Leadership appointments in areas such as operations, patient experience and marketing are also covered, providing insight into how the company supports its franchise network and retail healthcare model. For ongoing updates on JYNT, this news page aggregates these company communications in one place.
The Joint Corp (NASDAQ: JYNT) reported Q2 2025 financial results, highlighting a strategic shift toward becoming a pure-play franchisor. Revenue grew 5% to $13.3 million, with system-wide sales increasing 2.6% to $129.6 million. The company refranchised 37 clinics for $11.2 million and acquired Northwest regional developer territory rights for $2.8 million.
The company reported consolidated net income of $93,000, improving from a $3.6 million loss in Q2 2024. Adjusted EBITDA from consolidated operations increased 52% to $3.2 million. Due to softer sales trends, JYNT revised its 2025 guidance, now expecting system-wide sales of $530-550 million and low single-digit comp sales growth.
The total clinic count reached 967, with franchised clinics now representing 92% of the portfolio. The company maintains $29.8 million in unrestricted cash and a $20 million credit line.
The Joint Corp. (NASDAQ: JYNT) announced plans to restate its financial statements for full-year 2024 and Q1 2025 due to errors in calculating impairment charges for clinics held for sale. The restatement is expected to reduce the 2024 net loss by $2.2 million and increase Q1 2025 net income by $0.5 million, resulting in a cumulative $2.7 million increase in the carrying value of assets held for sale.
The company identified a misapplication of accounting guidance related to the valuation methodology for assets held for sale. While the restatement will not impact Adjusted EBITDA, cash positions, or restricted cash for either period, the company expects to report a material weakness in internal control over financial reporting and ineffective disclosure controls.
The Joint Corp. (NASDAQ: JYNT), the largest franchisor of chiropractic care through The Joint Chiropractic network, has scheduled its second quarter 2025 financial results announcement for Thursday, August 7, 2025, after market close.
The company will host a conference call at 5:00 p.m. EDT featuring President and CEO Sanjiv Razdan and CFO Scott Bowman. Investors can access the call by dialing (833) 630-0823 or (412) 317-1831. A live webcast with slides will be available on the company's IR events page, and an audio archive will be accessible for one week.
The Joint Corp (NASDAQ: JYNT) has completed a significant transaction involving the sale of 31 corporate-owned clinics in Arizona and New Mexico to Joint Ventures, LLC for $8.3 million in cash. As part of the deal, JYNT acquired regional developer rights in the Northwest region, which generated $855,000 in royalties and franchise fees over the 12 months ended March 31, 2025.
The acquired Northwest territory rights cover 46 existing franchised clinics and 30 sites for future development. Joint Ventures, one of JYNT's strongest franchisees, will grow to 96 clinics and has committed to opening 10 additional locations. The company expects this refranchising initiative to strengthen its business model, reduce commission obligations, and increase operating margins.
The Joint Corp. (NASDAQ: JYNT), the nation's largest chiropractic care franchisor, has launched its first official mobile app for iOS and Android platforms. The app introduces several key features to enhance patient experience, including a clinic locator, doctor availability checker, in-clinic check-in using geofencing technology, and push notifications for updates and promotions.
According to CEO Sanjiv Razdan, this technology investment aims to improve access to care and deliver a more seamless connection to their chiropractic services. The app launch follows a successful multi-phase beta test across various locations nationwide, marking a significant milestone in The Joint's commitment to making chiropractic care more accessible, affordable, and convenient.
The Joint Corp. (NASDAQ: JYNT) has announced significant strategic moves to strengthen its position as the largest pure play chiropractic care franchise system. The company has signed a binding agreement to sell 31 corporate clinics in Arizona and New Mexico to Joint Ventures, LLC, its largest franchisee, in exchange for cash and regional developer rights in the Northwest region.
Joint Ventures will increase its clinic count to 96 locations and has committed to opening 10 additional clinics. Additionally, The Joint has refranchised 5 clinics in the Kansas City region to Chiro 93, LLC. The Northwest region acquisition includes 46 existing franchised clinics and 30 sites for future development. These strategic moves aim to improve profitability by reducing regional developer commissions and increasing operating margins.